Rituximab Maintenance after Chemotherapy Gives Better Outcomes in Advanced Follicular Lymphoma

AudioMedica News

Rituximab Maintenance after Chemotherapy Gives Better Outcomes in Advanced Follicular Lymphoma

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

Sandra Horning

Abstract 349
Sandra Horning, Stanford University Medical Center
It is not necessary to use rituximab along with standard CVP (cyclophosphamide, vincristine, predinsone) induction therapy in patients with advanced follicular lymphoma. However, the use of rituximab maintenance, after induction therapy, brought clear benefits among patients in the study.

[audio:https://www.audiomedica.com/podcasting/ajo_14.2/01.sandra_horning.mp3]


Click here for all the interviews from ASH 2005